Stonepine Capital Management holds 6.9% · +6.6pp on the report before
Filed 08/26
StocksWho bought more than 5%?6.9%
All 5% stake reports on Edesa Biotech
Edesa Biotech EDSA
Health care sectorNasdaq
What to see in Edesa Biotech now
Company
- Exchange
- Nasdaq
- Sector
- Health care
- Industry
- Pharmaceutical Preparations
- Headquarters
- Markham
- Fiscal year end
- 09/30
- Next earnings
- 11/10, estimated
- Stonepine Capital Management holds 6.9% · +6.6pp on the report beforeFiled 08/26
5% stakes
| Holder | ||
|---|---|---|
| Stonepine Capital Management08/26 | 6.9%953,739 sh | +6.6pp |
| Pardeep Nijhawan08/25 | 16.31%2,613,492 sh | −3.7pp |
| Velan Capital Investment Management08/25 | 9.99%1,356,455 sh | +0.0pp |
| Integrated Core Strategies06/18 | 5.4%520,685 sh | First report |
| Pardeep Nijhawan06/16 | 19.99%2,210,022 sh | +0.0pp |
| Stonepine Capital Management05/15 | 0.3%30,000 sh | −9.6pp |
| Nantahala Capital Management05/15 | 0%0 sh | −10.0pp |
| Point72 Asset Management05/15 | 0%2 sh | −7.2pp |
| Rubric Capital Management05/15 | 7.74%687,500 sh | First report |
| Sirenia Capital Management05/15 | 7.2%600,000 sh | First report |
| Perceptive Advisors03/16 | 6.7%563,239 sh | First report |
| Point72 Asset Management03/03 | 7.2%600,000 sh | First report |
| Velan Capital Investment Management03/02 | 9.99%834,700 sh | +0.0pp |
| Pardeep Nijhawan03/02 | 19.99%2,040,785 sh | +0.0pp |
| Nantahala Capital Management25/05/15 | 9.99%700,488 sh | First report |
| Stonepine Capital Management25/02/25 | 9.9%693,551 sh | First report |
| Velan Capital Investment Management25/02/18 | 9.99%693,551 sh | First report |
| Thomas A. Satterfield Jr.25/02/18 | 0%0 sh | −6.7pp |
| Pardeep Nijhawan25/02/14 | 19.99%1,596,581 sh | No earlier report |
